In vivo selection of moxifloxacin-resistant Clostridium difficile.
作者信息
Mena Ana, Riera Elena, López-Causapé Carla, Weber Irene, Pérez José L, Oliver Antonio
出版信息
Antimicrob Agents Chemother. 2012 May;56(5):2788-9. doi: 10.1128/AAC.06433-11. Epub 2012 Feb 27.
Abstract
摘要
相似文献
1
In vivo selection of moxifloxacin-resistant Clostridium difficile.体内筛选耐莫西沙星的艰难梭菌
Antimicrob Agents Chemother. 2012 May;56(5):2788-9. doi: 10.1128/AAC.06433-11. Epub 2012 Feb 27.
2
Surface layer protein A variant of Clostridium difficile PCR-ribotype 027.艰难梭菌PCR核糖体分型027的表层蛋白A变体
Emerg Infect Dis. 2011 Feb;17(2):317-9. doi: 10.3201/eid1702.100355.
3
gyrA and gyrB mutations are implicated in cross-resistance to Ciprofloxacin and moxifloxacin in Clostridium difficile.gyrA和gyrB突变与艰难梭菌对环丙沙星和莫西沙星的交叉耐药性有关。
Antimicrob Agents Chemother. 2002 Nov;46(11):3418-21. doi: 10.1128/AAC.46.11.3418-3421.2002.
4
Clostridium difficile isolates resistant to fluoroquinolones in Italy: emergence of PCR ribotype 018.意大利对氟喹诺酮类药物具有抗药性的艰难梭菌分离株：出现 PCR 核糖型 018。
J Clin Microbiol. 2010 Aug;48(8):2892-6. doi: 10.1128/JCM.02482-09. Epub 2010 Jun 16.
5
Fluoroquinolone resistance and Clostridium difficile, Germany.氟喹诺酮类药物耐药与艰难梭菌，德国。
Emerg Infect Dis. 2010 Apr;16(4):675-7. doi: 10.3201/eid1604.090859.
6
Elevated levels of intestinal inflammation in Clostridium difficile infection associated with fluoroquinolone-resistant C. difficile.艰难梭菌感染中肠道炎症水平升高与耐氟喹诺酮类艰难梭菌有关。
J Hosp Infect. 2009 Oct;73(2):185-7. doi: 10.1016/j.jhin.2009.05.013. Epub 2009 Aug 26.
7
Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008.1990 年和 2008 年艰难梭菌分离株对抗红霉素和莫西沙星的耐药性比较、二元毒素基因的存在情况和 PCR 核糖体分型。
Eur J Clin Microbiol Infect Dis. 2010 Dec;29(12):1571-3. doi: 10.1007/s10096-010-1017-9. Epub 2010 Jul 15.
8
Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.对体外筛选出的耐氟喹诺酮艰难梭菌突变体的gyrA和gyrB喹诺酮耐药决定区的分子分析。
Antimicrob Agents Chemother. 2009 Jun;53(6):2463-8. doi: 10.1128/AAC.01252-08. Epub 2009 Apr 13.
9
Effects of subinhibitory concentrations of antibiotics on colonization factor expression by moxifloxacin-susceptible and moxifloxacin-resistant Clostridium difficile strains.亚抑菌浓度抗生素对莫西沙星敏感和耐药艰难梭菌定植因子表达的影响。
Antimicrob Agents Chemother. 2009 Dec;53(12):5155-62. doi: 10.1128/AAC.00532-09. Epub 2009 Oct 5.
10
In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.在利福昔明治疗期间体内筛选利福霉素耐药艰难梭菌。
Antimicrob Agents Chemother. 2012 Nov;56(11):6019-20. doi: 10.1128/AAC.00974-12. Epub 2012 Aug 20.
引用本文的文献
1
Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection.艰难梭菌的抗药性和耐药性降低：对艰难梭菌感染的诱导、治疗和复发的潜在影响。
Antibiotics (Basel). 2015 Jul 10;4(3):267-98. doi: 10.3390/antibiotics4030267.
2
In vivo selection of rifamycin-resistant Clostridium difficile during rifaximin therapy.在利福昔明治疗期间体内筛选利福霉素耐药艰难梭菌。
Antimicrob Agents Chemother. 2012 Nov;56(11):6019-20. doi: 10.1128/AAC.00974-12. Epub 2012 Aug 20.
本文引用的文献
1
Detection of Clostridium difficile infection.艰难梭菌感染的检测。
Infect Control Hosp Epidemiol. 2010 Nov;31 Suppl 1:S35-7. doi: 10.1086/655999.
2
Molecular characterization of moxifloxacin resistance from Canadian Clostridium difficile clinical isolates.加拿大艰难梭菌临床分离株中莫西沙星耐药的分子特征。
Diagn Microbiol Infect Dis. 2010 Apr;66(4):419-24. doi: 10.1016/j.diagmicrobio.2009.12.002.
3
Multilocus sequence typing of Clostridium difficile.艰难梭菌多位点序列分型。
J Clin Microbiol. 2010 Mar;48(3):770-8. doi: 10.1128/JCM.01796-09. Epub 2009 Dec 30.
4
Molecular analysis of the gyrA and gyrB quinolone resistance-determining regions of fluoroquinolone-resistant Clostridium difficile mutants selected in vitro.对体外筛选出的耐氟喹诺酮艰难梭菌突变体的gyrA和gyrB喹诺酮耐药决定区的分子分析。
Antimicrob Agents Chemother. 2009 Jun;53(6):2463-8. doi: 10.1128/AAC.01252-08. Epub 2009 Apr 13.
5
Clostridium difficile infections in a Shanghai hospital: antimicrobial resistance, toxin profiles and ribotypes.上海某医院艰难梭菌感染情况：抗菌药物耐药性、毒素谱及核糖型
Int J Antimicrob Agents. 2009 Apr;33(4):339-42. doi: 10.1016/j.ijantimicag.2008.09.022. Epub 2008 Dec 20.
6
Fluoroquinolone resistance in Clostridium difficile isolates from a prospective study of C. difficile infections in Europe.欧洲艰难梭菌感染前瞻性研究中艰难梭菌分离株对氟喹诺酮的耐药性
J Med Microbiol. 2008 Jun;57(Pt 6):784-789. doi: 10.1099/jmm.0.47738-0.
7
gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027.耐氟喹诺酮艰难梭菌PCR-027中的gyrA突变
Emerg Infect Dis. 2007 Mar;13(3):504-5. doi: 10.3201/eid1303.060771.
8
Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain.莫西沙星治疗作为一次暴发期间艰难梭菌相关疾病的危险因素：控制一种新流行菌株的尝试
Infect Control Hosp Epidemiol. 2007 Feb;28(2):198-201. doi: 10.1086/511789. Epub 2007 Jan 25.
9
High-level resistance to moxifloxacin and gatifloxacin associated with a novel mutation in gyrB in toxin-A-negative, toxin-B-positive Clostridium difficile.与毒素A阴性、毒素B阳性艰难梭菌gyrB基因新突变相关的对莫西沙星和加替沙星的高水平耐药性。
J Antimicrob Chemother. 2006 Dec;58(6):1264-7. doi: 10.1093/jac/dkl398. Epub 2006 Oct 3.
10
An epidemic, toxin gene-variant strain of Clostridium difficile.一种艰难梭菌的流行、毒素基因变异菌株。
N Engl J Med. 2005 Dec 8;353(23):2433-41. doi: 10.1056/NEJMoa051590. Epub 2005 Dec 1.
Zotero 插件